David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
PUT
Carpenter Technology
CRS
$23.6B
| $470K | ﹤0.01% |
+1,700
| New | +$371K |
|
3552
First Trust Technology AlphaDEX Fund
FXL
$2.71B
| $469K | ﹤0.01% |
2,982
| – | – |
|
3553
PUT
Spectrum Brands
SPB
$2.03B
| $466K | ﹤0.01% |
+8,800
| New | +$525K |
|
3554
Bioventus
BVS
$958M
| $466K | ﹤0.01% |
70,442
-97,309
| -58% | -$690K |
|
3555
LGI Homes
LGIH
$1.35B
| $466K | ﹤0.01% |
9,044
-21,566
| -70% | -$1.18M |
|
3556
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $464K | ﹤0.01% |
4,658
+1,900
| +69% | +$176K |
|
3557
PUT
Universal Display
OLED
$3.89B
| $463K | ﹤0.01% |
3,000
| – | – |
|
3558
Donegal Group Class A
DGICA
$705M
| $463K | ﹤0.01% |
23,126
-21,068
| -48% | -$409K |
|
3559
Clarus
CLAR
$146M
| $463K | ﹤0.01% |
133,451
-71,675
| -35% | -$243K |
|
3560
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $461K | ﹤0.01% |
3,399
+728
| +27% | +$96.5K |
|
3561
Winnebago Industries
WGO
$909M
| $461K | ﹤0.01% |
15,889
-15,620
| -50% | -$512K |
|
3562
RBC Bearings
RBC
$15.7B
| $461K | ﹤0.01% |
1,197
-888
| -43% | -$313K |
|
3563
iShares MSCI China A ETF
CNYA
$222M
| $461K | ﹤0.01% |
16,048
+3,791
| +31% | +$105K |
|
3564
Bar Harbor Bankshares
BHB
$664M
| $460K | ﹤0.01% |
15,367
+2,353
| +18% | +$68.9K |
|
3565
Plains GP Holdings
PAGP
$5.4B
| $459K | ﹤0.01% |
23,600
-418,070
| -95% | -$7.78M |
|
3566
CALL
PagerDuty
PD
$956M
| $458K | ﹤0.01% |
30,000
| – | – |
|
3567
Delek US
DK
$4.17B
| $457K | ﹤0.01% |
+21,588
| New | +$363K |
|
3568
CALL
DaVita
DVA
$11.3B
| $456K | ﹤0.01% |
3,200
| – | – |
|
|
DHIL
3569
DELISTED
Diamond Hill
DHIL
| $454K | ﹤0.01% |
3,124
+389
| +14% | +$53.5K |
|
3570
CALL
Weatherford International
WFRD
$6.36B
| $453K | ﹤0.01% |
+9,000
| New | +$418K |
|
3571
CALL
Freedom Holding
FRHC
$10B
| $453K | ﹤0.01% |
+3,100
| New | +$458K |
|
3572
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$262M
| $449K | ﹤0.01% |
8,106
| – | – |
|
3573
Greif Class B
GEF.B
$4.13B
| $447K | ﹤0.01% |
6,479
-618
| -9% | -$37.5K |
|
3574
Eve Holding Inc Warrants
EVEX.WS
$30.3M
| $447K | ﹤0.01% |
484,473
| – | – |
|
3575
SelectQuote
SLQT
$137M
| $446K | ﹤0.01% |
+187,553
| New | +$492K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.